Biochemically, patients present with low circulating levels of fibroblast growth factor 23 (FGF23) and parathyroid hormone (PTH) [7], likely resulting (at least partly) from tubular phosphate leak and in contrast to patients with chronic kidney disease (CKD) with a different primary diagnosis. This evidence concerns the gene PTH and chronic kidney disease.